Blood Cancer United
Washington D.C., District of Columbia, 20005, United States
Location status: Recruiting
Location contact
D
CONTACT
Elisa S Weiss, PhD
PRINCIPAL_INVESTIGATOR
Research Coordinator
CONTACT
Recruiting
NCT Number: NCT07413991
Expressive Writing Program Among Young Adults With Blood Cancer
The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness.
Participants will
* Take part in an online expressive writing workshop for four weeks * Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
About this study
The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness.
Participants will
- Take part in an online expressive writing workshop for four weeks
- Take three surveys at different times over 12 weeks Participants will be randomly assigned to one of two study groups by chance. Group 1 will start the workshop the following week. Group 2 will wait 4 weeks before starting the workshop. The workshop is the same for both groups. Each week, participants will be given a writing prompt and asked to spend at least 15 minutes writing a response. They will be able to share their writing response in a private online community group if they would like, but sharing is not required.
Researchers will then compare changes in mental wellness between group 1 and 2.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient with a hematologic malignancy diagnosis in treatment or after treatment is completed, who is currently between the ages of 18 and 39 (young adult), or the informal caregiver of a young adult blood cancer patient
- Located within the U.S., Canada, or U.S. territories
- Able to read and write in English
Exclusion criteria
- Located outside of the U.S., Canada, or its territories
- Participant is a minor aged 17 years or below
Treatment and study plan
Expressive Writing Workshop
BehavioralGroup 1 will start the workshop the following week. Group 2 will wait 4 weeks before starting the workshop. There is an equal chance of being placed group 1 or group 2. You cannot choose your study group. The workshop is the same for both groups.
Primary outcomes
-
Mental Wellbeing
Time frame: Baseline, 4, and 8 weeks
Participants' mental wellbeing will be evaluated using the Warwick Edinburgh Mental Wellbeing Scale (WEMWBS), specifically the original 14-item scale developed by researchers at the University of Warwick and the University of Edinburgh in 2007. This self-report questionnaire asks questions about participants' feelings and how they have been functioning over the last two weeks to capture a comprehensive view of their recent mental wellbeing. Participants will rate each question on a 5-point Likert scale, and their responses will be totaled to a mental wellbeing score ranging from 14-70; higher scores indicate greater wellbeing.
-
Perceived Stress
Time frame: Baseline, 4, and 8 weeks
A self-report questionnaire captures whether participants perceive different life situations as overwhelming or uncontrollable. Participants will rate each question on a 5-point Likert scale, and their responses will be totaled to a stress score ranging from 0-40, with higher score indicated more perceived stress.
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Blood Cancer United
Other
Registry information
Official study title
An Expressive Writing Program to Support Emotional Wellness Among Young Adults With Hematologic Malignancy
Important dates
- Study start
- 2026
- Primary completion
- 2026
- Study completion
- 2026
- First posted
- Feb 17, 2026
- Registry last updated
- May 7, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Recruiting
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
NCT07203534
Hematologic Diseases, Hematologic Malignancy
Charlotte, North Carolina, United States
View Trial Details
Recruiting
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
NCT07257419
Disease Attributes, Hematologic Diseases
Memphis, Tennessee, United States
View Trial Details
Recruiting
Implementation of an Oral Chemotherapy Adherence Intervention
NCT06989489
Hematologic Diseases, Hematologic Malignancy
Chapel Hill, North Carolina, United States
View Trial Details
Recruiting
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
NCT06532773
Hematologic Diseases, Hematologic Malignancy
Durham, North Carolina, United States
View Trial Details